Refinement of intermediate-risk Karyotypes according to the IPSS-R in patients with myelodysplastic neoplasms (MDS). - Nachtkamp, K.; Schulz, F.; Kasprzak, A.; Strupp, C.; Hildebrandt, B.; Pfeilstöcker, M.; Valent, P.; Blum, B.; Giagounidis, A.; Götze, K.; Flatten, V.; Dietrich, S.; et al. (Annals of Hematology, 2025)